Skip to main content
Premium Trial:

Request an Annual Quote

One Codex, 4bases Ink Collaboration for Clinical Microbiome Analysis Solutions

NEW YORK – Next-generation sequencing data analysis platform company One Codex said on Thursday that it has formed a partnership with Swiss clinical product manufacturer 4bases to bring sample-to-report microbiome analysis solutions to clinicians in the EU.

Financial details of the deal were not disclosed.

According to One Codex, the collaboration will integrate its cloud-based SaaS platform, designed for the identification of bacteria, viruses, protists, and fungi, with 4bases' clinically validated microbial analysis panels using short- and long-read sequencing.

The integrated solution will be validated to CE-IVD standards, "ensuring compliance and enabling clinicians to utilize microbiome analysis in their patient care routines," One Codex said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.